Understanding a Positive Nucleic Acid Amplification Test (NAAT) for a Sexually Transmitted Infection

Overview

A nucleic acid amplification test (NAAT) is a laboratory method that detects the genetic material (DNA or RNA) of a pathogen with very high sensitivity and specificity. In the context of sexually transmitted infections (STIs), NAATs are the gold‑standard for diagnosing chlamydia, gonorrhea, trichomoniasis, Mycoplasma genitalium, and some viral infections such as herpes simplex virus (HSV) and human papillomavirus (HPV) when performed on appropriate specimens.

When a health‑care provider says you have a “NAAT‑positive STI,” it means that the test found the DNA/RNA of a particular STI‑causing microbe in the sample you provided (urine, vaginal swab, penile swab, rectal swab, or throat swab). This result confirms an active infection that requires treatment.

• Who it affects: Anyone who is sexually active can acquire an STI. Adolescents and young adults (ages 15–24) account for nearly half of all new STIs in the United States, according to the CDC.¹
• Prevalence of NAAT‑detected infections (2022 data, U.S.):
  • Chlamydia: 1.8 million cases (≈1,300 per 100,000 people).
  • Gonorrhea: 677,000 cases (≈490 per 100,000).
  • Trichomoniasis: ~2.5 million cases, many detected only by NAAT.

Symptoms

Many STIs are asymptomatic, which is why routine screening with NAATs is crucial. When symptoms do appear, they vary by pathogen and anatomic site.

Chlamydia (CT)

• Women: Abnormal vaginal discharge, burning during urination, lower abdominal or pelvic pain, intermenstrual spotting.
• Men: Penile discharge, burning or itching at the urethral opening, testicular pain.

Gonorrhea (NG)

• Similar to chlamydia but often more purulent discharge.
• Rectal infection: pain, discharge, bleeding.
• Pharyngeal infection: sore throat, often silent.

Trichomoniasis (TV)

• Women: Frothy, yellow‑green vaginal discharge with a “fishy” odor, itching, discomfort during intercourse.
• Men: Often no symptoms; possible urethral discharge or irritation.

Mycoplasma genitalium

• Urethritis in men (discharge, burning), cervicitis or pelvic pain in women.

Viral NAATs (HSV, HPV)

• HSV: Painful vesicles or ulcers on genitals or mouth.
• HPV: Usually asymptomatic; may cause genital warts or be detected in cervical cytology.

Causes and Risk Factors

A NAAT‑positive result reflects the presence of a specific organism. The underlying cause is exposure to infected bodily fluids during sexual activity.

• Unprotected vaginal, anal, or oral sex with an infected partner.
• Multiple or concurrent partners increase the probability of encountering an infected individual.
• Inconsistent condom use – condoms dramatically reduce transmission but are less effective for infections that affect uncovered areas (e.g., HSV on the skin).
• History of prior STIs – prior infection can indicate higher risk behaviors.
• Substance use (alcohol, drugs) that impairs judgment and leads to risky sexual encounters.
• Biological factors: Women are biologically more susceptible to certain STIs because of a larger mucosal surface area and the presence of cervical ectopy.
• Age: People under 25 have higher incidence rates.
• Men who have sex with men (MSM) have higher rates of rectal gonorrhea and chlamydia.

Diagnosis

When an STI is suspected, clinicians rely on NAAT because it is:

• Highly sensitive (detects low‑level infection).
• Highly specific (few false‑positives).
• Applicable to urine, self‑collected swabs, or clinician‑collected swabs.

Step‑by‑step diagnostic pathway

1. Clinical assessment – review of symptoms, sexual history, and risk factors.
2. Specimen collection – first‑catch urine for men, vaginal or cervical swab for women, rectal and pharyngeal swabs when indicated.
3. Laboratory NAAT – PCR (polymerase chain reaction) or TMA (transcription mediated amplification) platforms (e.g., Aptima, GeneXpert).
4. Result reporting – Positive = presence of pathogen DNA/RNA; Negative = not detected (but does not rule out early infection).
5. Confirmatory testing (rare) – Some labs may repeat the test or use a second target gene if the result is unexpected.

In addition to NAAT, clinicians may order:

• Complete blood count (CBC) if systemic symptoms present.
• Ultrasound or pelvic exam for suspected pelvic inflammatory disease (PID).
• HIV and syphilis screening, as co‑infection is common.

Treatment Options

Treatment is pathogen‑specific, short‑acting, and highly effective when taken as prescribed.

Chlamydia

• Doxycycline 100 mg orally twice daily for 7 days (preferred).
• Alternative: Azithromycin 1 g orally single dose (used when adherence to a 7‑day regimen is uncertain).

Gonorrhea

• Ceftriaxone 500 mg intramuscular single dose (1 g for weight ≥ 150 kg) plus Doxycycline 100 mg twice daily for 7 days to cover possible chlamydia co‑infection.
• For penicillin‑allergic patients, cefixime 800 mg orally single dose may be used.

Trichomoniasis

• Metronidazole 2 g orally single dose or 500 mg twice daily for 7 days.
• Partner treatment is essential to prevent reinfection.

Mycoplasma genitalium

• Azithromycin 1 g on day 1, then 500 mg daily for 4 days, **or** a 7‑day doxycycline course followed by a macrolide if resistance is suspected.

HSV (viral NAAT positive)

• Acute outbreaks: Acyclovir 400 mg five times daily for 7‑10 days, or valacyclovir 1 g twice daily.
• Suppressive therapy (for frequent recurrences): Valacyclovir 500 mg daily.

HPV

• There is no antiviral treatment; management focuses on removal of warts (cryotherapy, podophyllin) and regular cervical cancer screening.

Lifestyle & Supportive Measures

• Complete the full medication course—even if symptoms resolve.
• Avoid sexual activity until treatment is completed and a test‑of‑cure (if indicated) is negative.
• Notify all recent sexual partners so they can be tested and treated.
• Consider condom use or dental dams consistently.

Living with a NAAT‑Positive STI

Receiving a positive result can be stressful. Below are practical tips to help you manage daily life while undergoing treatment and after recovery.

• Take medications exactly as prescribed. Use a pill organizer or phone alarms.
• Maintain follow‑up appointments. Some infections (e.g., gonorrhea) require a test‑of‑cure 1‑2 weeks after therapy.
• Practice good genital hygiene. Gentle washing with warm water; avoid douches or scented products that can disrupt normal flora.
• Limit alcohol and recreational drug use while on antibiotics to reduce side effects and improve adherence.
• Emotional support. Talk to a trusted friend, counselor, or join a support group for STI‑positive individuals.
• Contraception. If you are not ready for pregnancy, discuss reliable birth control methods with your provider.
• Sexual health education. Learn about safer‑sex practices to protect yourself and partners in the future.

Prevention

Prevention reduces both the risk of acquiring a new STI and the chance of transmitting an existing one.

• Consistent condom use (male or female) for vaginal, anal, and oral sex.
• Pre‑exposure prophylaxis (PrEP) for HIV is recommended for high‑risk individuals; it does not protect against other STIs, so condom use remains important.
• Routine screening:
  • Women < 25 y or those with risk factors: annual chlamydia & gonorrhea NAAT.
  • MSM: at least annual rectal and pharyngeal NAATs.
  • Pregnant women: early prenatal screening for chlamydia, gonorrhea, syphilis, HIV, and hepatitis B.
• Vaccination: HPV vaccine (recommended up to age 45) and hepatitis B vaccine.
• Limit number of sexual partners and engage in mutually monogamous relationships where both partners are tested.
• Avoid sharing sex toys without cleaning or using condoms on the devices.

Complications

If left untreated, many STIs can cause short‑term discomfort and long‑term health problems.

• Pelvic Inflammatory Disease (PID) – Ascending infection from chlamydia or gonorrhea leading to chronic pelvic pain, infertility, or ectopic pregnancy.
• Epididymitis in men – Painful swelling of the testicle, possible infertility.
• Increased HIV acquisition risk – Inflammation from an STI makes mucosal transmission easier.
• Neonatal infections – Pregnant women with untreated chlamydia, gonorrhea, or syphilis can transmit disease to the newborn (conjunctivitis, pneumonia, sepsis).
• Chronic prostatitis – Persistent urinary symptoms after gonorrhea/chlamydia.
• Recurrent urinary tract infections – Especially with Mycoplasma genitalium.
• Cancer risk – Persistent high‑risk HPV can lead to cervical, anal, or oropharyngeal cancer.

When to Seek Emergency Care

---

**References**

1. Centers for Disease Control and Prevention (CDC). Sexually Transmitted Disease Surveillance 2020.
2. Mayo Clinic. Chlamydia: Symptoms & Causes.
3. World Health Organization (WHO). Fact Sheet: Sexually Transmitted Infections.
4. Cleveland Clinic. Gonorrhea.
5. National Institutes of Health (NIH) – U.S. National Library of Medicine. Current management of Mycoplasma genitalium infection.